Search Ontology:
ChEBI
emtricitabine
- Term ID
- CHEBI:31536
- Synonyms
-
- (-)-(2R,5S)-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
- (-)-2'-deoxy-5-fluoro-3'-thiacytidine
- (-)-beta-2',3'-dideoxy-5-fluoro-3'-thiacytidine
- (-)-cis-4-amino-5-fluoro-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one
- (-)-FTC
- (2R-cis)-4-amino-5-fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone
- 4-amino-5-fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one
- 4-Amino-5-fluoro-1-((2R,5S)-2-hydroxymethyl-[1,3]oxathiolan-5-yl)-1H-pyrimidin-2-one
- 4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one
- 5-fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine
- EMTRICITABINE
- Definition
- An organofluorine compound that is 5-fluorocytosine substituted at the 1 position by a 2-(hydroxymethyl)-1,3-oxathiolan-5-yl group (2R,5S configuration). It is used in combination therapy for the treatment of HIV-1 infection.
- References
-
- Beilstein:5908714
- CAS:143491-57-0
- DrugBank:DB00879
- Drug_Central:1003
- KEGG:C12599
- KEGG:D01199
- PDBeChem:ETV
- PMID:11491420
- PMID:14609348
- PMID:14693538
- PMID:15206508
- PMID:15249567
- PMID:15588339
- PMID:15875341
- PMID:15977972
- PMID:16034488
- PMID:16323102
- PMID:16401810
- PMID:17526857
- PMID:19493710
- PMID:22915463
- PMID:22917277
- PMID:22935078
- PMID:23337366
- PMID:23361642
- PMID:25017682
- Patent:US5538975
- Patent:WO9214743
- Wikipedia:Emtricitabine
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
- is a type of
-
- has_role
-
- inverse has_part
-
Phenotype
Phenotype resulting from emtricitabine
Phenotype where environments contain emtricitabine
Phenotype modified by environments containing emtricitabine
Human Disease / Model Data